Thyroid hormone-related regulation of gene expression in human fatty liver

Jussi Pihlajamäki, Tanner Boes, Eun Young Kim, Farrell Dearie, Brian W. Kim, Joshua Schroeder, Edward Mun, Imad Nasser, Peter J. Park, Antonio C. Bianco, Allison B. Goldfine, Mary Elizabeth Patti

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Context: Fatty liver is an important complication of obesity; however, regulatory mechanisms mediating altered gene expression patterns have not been identified. Objective: The aim of the study was to identify novel transcriptional changes in human liver that could contribute to hepatic lipid accumulation and associated insulin resistance, type 2 diabetes, and nonalcoholic steatohepatitis. Design: We evaluated gene expression in surgical liver biopsies from 13 obese (nine with type 2 diabetes) and five control subjects using Affymetrix U133A microarrays. PCR validation was performed in liver biopsies using an additional 16 subjects.Wealso tested thyroid hormone responses in mice fed chow or high-fat diet. Setting: Recruitment was performed in an academic medical center. Participants: Individuals undergoing elective surgery for obesity or gallstones participated in the study. Results: The top-ranking gene set, down-regulated in obese subjects, was comprised of genes previously demonstrated to be positively regulated by T3 in human skeletal muscle (n = 399; P < 0.001; false discovery rate = 0.07). This gene set included genes related to RNA metabolism (SNRPE, HNRPH3, TIA1, and SFRS2), protein catabolism (PSMA1, PSMD12, USP9X, IBE2B, USP16, and PCMT1), and energy metabolism (ATP5C1, COX7C, UQCRB). We verified thyroid hormone regulation of these genes in the liver after injection of C57BL/6J mice with T3 (100 μg/100 g bodyweight); furthermore, T3-induced increases in expression of these genes were abolished by high-fat diet. In agreement, expression of these genes inversely correlated with liver fat content in humans. Conclusions: These data suggest that impaired thyroid hormone action may contribute to altered patterns of gene expression in fatty liver.

Original languageEnglish
Pages (from-to)3521-3529
Number of pages9
JournalJournal of Clinical Endocrinology and Metabolism
Volume94
Issue number9
DOIs
StatePublished - Sep 1 2009

Fingerprint

Gene Expression Regulation
Fatty Liver
Thyroid Hormones
Gene expression
Liver
Genes
Gene Expression
High Fat Diet
Biopsy
Fats
Type 2 Diabetes Mellitus
Nutrition
Medical problems
Obesity
Gallstones
Inbred C57BL Mouse
Energy Metabolism
Microarrays
Insulin Resistance
Metabolism

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Pihlajamäki, J., Boes, T., Kim, E. Y., Dearie, F., Kim, B. W., Schroeder, J., ... Patti, M. E. (2009). Thyroid hormone-related regulation of gene expression in human fatty liver. Journal of Clinical Endocrinology and Metabolism, 94(9), 3521-3529. https://doi.org/10.1210/jc.2009-0212

Thyroid hormone-related regulation of gene expression in human fatty liver. / Pihlajamäki, Jussi; Boes, Tanner; Kim, Eun Young; Dearie, Farrell; Kim, Brian W.; Schroeder, Joshua; Mun, Edward; Nasser, Imad; Park, Peter J.; Bianco, Antonio C.; Goldfine, Allison B.; Patti, Mary Elizabeth.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 94, No. 9, 01.09.2009, p. 3521-3529.

Research output: Contribution to journalArticle

Pihlajamäki, J, Boes, T, Kim, EY, Dearie, F, Kim, BW, Schroeder, J, Mun, E, Nasser, I, Park, PJ, Bianco, AC, Goldfine, AB & Patti, ME 2009, 'Thyroid hormone-related regulation of gene expression in human fatty liver', Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3521-3529. https://doi.org/10.1210/jc.2009-0212
Pihlajamäki, Jussi ; Boes, Tanner ; Kim, Eun Young ; Dearie, Farrell ; Kim, Brian W. ; Schroeder, Joshua ; Mun, Edward ; Nasser, Imad ; Park, Peter J. ; Bianco, Antonio C. ; Goldfine, Allison B. ; Patti, Mary Elizabeth. / Thyroid hormone-related regulation of gene expression in human fatty liver. In: Journal of Clinical Endocrinology and Metabolism. 2009 ; Vol. 94, No. 9. pp. 3521-3529.
@article{888783ecd4494544a27e7d0bf3cc42c9,
title = "Thyroid hormone-related regulation of gene expression in human fatty liver",
abstract = "Context: Fatty liver is an important complication of obesity; however, regulatory mechanisms mediating altered gene expression patterns have not been identified. Objective: The aim of the study was to identify novel transcriptional changes in human liver that could contribute to hepatic lipid accumulation and associated insulin resistance, type 2 diabetes, and nonalcoholic steatohepatitis. Design: We evaluated gene expression in surgical liver biopsies from 13 obese (nine with type 2 diabetes) and five control subjects using Affymetrix U133A microarrays. PCR validation was performed in liver biopsies using an additional 16 subjects.Wealso tested thyroid hormone responses in mice fed chow or high-fat diet. Setting: Recruitment was performed in an academic medical center. Participants: Individuals undergoing elective surgery for obesity or gallstones participated in the study. Results: The top-ranking gene set, down-regulated in obese subjects, was comprised of genes previously demonstrated to be positively regulated by T3 in human skeletal muscle (n = 399; P < 0.001; false discovery rate = 0.07). This gene set included genes related to RNA metabolism (SNRPE, HNRPH3, TIA1, and SFRS2), protein catabolism (PSMA1, PSMD12, USP9X, IBE2B, USP16, and PCMT1), and energy metabolism (ATP5C1, COX7C, UQCRB). We verified thyroid hormone regulation of these genes in the liver after injection of C57BL/6J mice with T3 (100 μg/100 g bodyweight); furthermore, T3-induced increases in expression of these genes were abolished by high-fat diet. In agreement, expression of these genes inversely correlated with liver fat content in humans. Conclusions: These data suggest that impaired thyroid hormone action may contribute to altered patterns of gene expression in fatty liver.",
author = "Jussi Pihlajam{\"a}ki and Tanner Boes and Kim, {Eun Young} and Farrell Dearie and Kim, {Brian W.} and Joshua Schroeder and Edward Mun and Imad Nasser and Park, {Peter J.} and Bianco, {Antonio C.} and Goldfine, {Allison B.} and Patti, {Mary Elizabeth}",
year = "2009",
month = "9",
day = "1",
doi = "10.1210/jc.2009-0212",
language = "English",
volume = "94",
pages = "3521--3529",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Thyroid hormone-related regulation of gene expression in human fatty liver

AU - Pihlajamäki, Jussi

AU - Boes, Tanner

AU - Kim, Eun Young

AU - Dearie, Farrell

AU - Kim, Brian W.

AU - Schroeder, Joshua

AU - Mun, Edward

AU - Nasser, Imad

AU - Park, Peter J.

AU - Bianco, Antonio C.

AU - Goldfine, Allison B.

AU - Patti, Mary Elizabeth

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Context: Fatty liver is an important complication of obesity; however, regulatory mechanisms mediating altered gene expression patterns have not been identified. Objective: The aim of the study was to identify novel transcriptional changes in human liver that could contribute to hepatic lipid accumulation and associated insulin resistance, type 2 diabetes, and nonalcoholic steatohepatitis. Design: We evaluated gene expression in surgical liver biopsies from 13 obese (nine with type 2 diabetes) and five control subjects using Affymetrix U133A microarrays. PCR validation was performed in liver biopsies using an additional 16 subjects.Wealso tested thyroid hormone responses in mice fed chow or high-fat diet. Setting: Recruitment was performed in an academic medical center. Participants: Individuals undergoing elective surgery for obesity or gallstones participated in the study. Results: The top-ranking gene set, down-regulated in obese subjects, was comprised of genes previously demonstrated to be positively regulated by T3 in human skeletal muscle (n = 399; P < 0.001; false discovery rate = 0.07). This gene set included genes related to RNA metabolism (SNRPE, HNRPH3, TIA1, and SFRS2), protein catabolism (PSMA1, PSMD12, USP9X, IBE2B, USP16, and PCMT1), and energy metabolism (ATP5C1, COX7C, UQCRB). We verified thyroid hormone regulation of these genes in the liver after injection of C57BL/6J mice with T3 (100 μg/100 g bodyweight); furthermore, T3-induced increases in expression of these genes were abolished by high-fat diet. In agreement, expression of these genes inversely correlated with liver fat content in humans. Conclusions: These data suggest that impaired thyroid hormone action may contribute to altered patterns of gene expression in fatty liver.

AB - Context: Fatty liver is an important complication of obesity; however, regulatory mechanisms mediating altered gene expression patterns have not been identified. Objective: The aim of the study was to identify novel transcriptional changes in human liver that could contribute to hepatic lipid accumulation and associated insulin resistance, type 2 diabetes, and nonalcoholic steatohepatitis. Design: We evaluated gene expression in surgical liver biopsies from 13 obese (nine with type 2 diabetes) and five control subjects using Affymetrix U133A microarrays. PCR validation was performed in liver biopsies using an additional 16 subjects.Wealso tested thyroid hormone responses in mice fed chow or high-fat diet. Setting: Recruitment was performed in an academic medical center. Participants: Individuals undergoing elective surgery for obesity or gallstones participated in the study. Results: The top-ranking gene set, down-regulated in obese subjects, was comprised of genes previously demonstrated to be positively regulated by T3 in human skeletal muscle (n = 399; P < 0.001; false discovery rate = 0.07). This gene set included genes related to RNA metabolism (SNRPE, HNRPH3, TIA1, and SFRS2), protein catabolism (PSMA1, PSMD12, USP9X, IBE2B, USP16, and PCMT1), and energy metabolism (ATP5C1, COX7C, UQCRB). We verified thyroid hormone regulation of these genes in the liver after injection of C57BL/6J mice with T3 (100 μg/100 g bodyweight); furthermore, T3-induced increases in expression of these genes were abolished by high-fat diet. In agreement, expression of these genes inversely correlated with liver fat content in humans. Conclusions: These data suggest that impaired thyroid hormone action may contribute to altered patterns of gene expression in fatty liver.

UR - http://www.scopus.com/inward/record.url?scp=69949111082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69949111082&partnerID=8YFLogxK

U2 - 10.1210/jc.2009-0212

DO - 10.1210/jc.2009-0212

M3 - Article

VL - 94

SP - 3521

EP - 3529

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 9

ER -